Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ACTIVE ANTIRETROVIRAL THERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 673 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pomerantz, RJ
      Reservoirs of human immunodeficiency virus type 1: The main obstacles to viral eradication

      CLINICAL INFECTIOUS DISEASES
    2. Skiest, DJ
      Focal neurological disease in patients with acquired immunodeficiency syndrome

      CLINICAL INFECTIOUS DISEASES
    3. Gerna, G; Piccinini, G; Genini, E; Percivalle, E; Zavattoni, M; Lilleri, D; Testa, L; Comolli, G; Maserati, T; Baldanti, F; Maccario, R; Monforte, AD; Revello, MG
      Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Zinkernagel, C; Taffe, P; Rickenbach, M; Amiet, R; Ledergerber, B; Volkart, AC; Rauchfleisch, U; Kiss, A; Werder, V; Vernazza, P; Battegay, M
      Importance of mental health assessment in HIV-infected outpatients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Beinker, NK; Mayers, DL; Lange, CG; Valdez, H; Sitkins, J; Lemonnier, L; Chowdhry, TK; Lederman, MM
      Genotypic drug resistance and cause of death in HIV-infected persons who died in 1999

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Monforte, AD; Bugarini, R; Pezzotti, P; De Luca, A; Antinori, A; Mussini, C; Vigevani, GM; Tirelli, U; Bruno, R; Gritti, F; Piazza, M; Chigiotti, S; Chirianni, A; De Stefano, C; Pizzigallo, E; Perrella, O; Moroni, M
      Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    7. Lafeuillade, A; Poggi, C; Chadapaud, S; Hittinger, G; Chouraqui, M; Delbeke, E
      HIV-1 induction-maintenance at the lymph node level: The "Apollo-97" study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    8. Tozzi, V; Balestra, T; Galgani, S; Narciso, P; Sampaolesi, A; Antinori, A; Giulianelli, M; Serraino, I; Ippolito, G
      Changes in neurocognitive performance in a cohort of patients treated withHAART for 3 years

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    9. Rey, D; Schmitt, MP; Partisani, M; Hess-Kempf, G; Krantz, W; de Mautort, E; Bernard-Henry, C; Priester, M; Cheneau, C; Lang, JM
      Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: A median follow-up of 64 weeks

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    10. Easterbrook, PJ; Newson, R; Ives, N; Pereira, S; Moyle, G; Gazzard, BG
      Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    11. Le Moing, V; Chene, G; Carrieri, MP; Besnier, JM; Masquelier, B; Salamon, R; Bazin, C; Moatti, JP; Raffi, F; Leport, C
      Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Leng, QB; Borkow, G; Weisman, Z; Stein, M; Kalinkovich, A; Bentwich, Z
      Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    13. Lucas, GM; Cheever, LW; Chaisson, RE; Moore, RD
      Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    14. Jensen-Fangel, S; Thomsen, HF; Larsen, L; Black, FT; Obel, N
      The effect of nevirapine in combination with nelfinavir in heavily pretreated HIV-1-infected patients - A prospective, open-label, controlled, randomized study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    15. Gebo, KA; Diener-West, M; Moore, RD
      Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    16. Brambilla, AM; Castagna, A; Nocita, B; Hasson, H; Boeri, E; Veglia, F; Lazzarin, A
      Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    17. Nelson, PW; Mittler, JE; Perelson, AS
      Effect of drug efficacy and the eclipse phase of the viral life cycle on estimates of HIV viral dynamic parameters

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    18. Bangsberg, DR; Hecht, FM; Clague, H; Charlebois, ED; Ciccarone, D; Chesney, M; Moss, A
      Provider assessment of adherence to HIV antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    19. Para, MF; Kalish, LA; Collier, AC; Pollard, RB; Kumar, PN; Mintz, L; Wallach, FR; Drew, WL
      Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    20. Talal, AH; Irwin, CE; Dieterich, DT; Yee, H; Zhang, LQ
      Effect of HIV-1 infection on lymphocyte proliferation in gut-associated lymphoid tissue

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    21. Talal, AH; Monard, S; Vesanen, M; Zheng, ZY; Hurley, A; Cao, YZ; Fang, F; Smiley, L; Johnson, J; Kost, R; Markowitz, MH
      Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    22. Rousseau, MN; Vergne, L; Montes, B; Peeters, M; Reynes, J; Delaporte, E; Segondy, M
      Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    23. Miller, V
      Resistance to protease inhibitors

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    24. Miller, KD; Spooner, K; Herpin, BR; Rock-Kress, D; Metcalf, JA; Davey, RT; Falloon, J; Kovacs, JA; Polis, RA; Walker, RE; Masur, H; Lane, HC
      Immunotherapy of HIV-infected patients with intermittent interleukin-2: Effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion

      CLINICAL IMMUNOLOGY
    25. Montaner, LJ
      Structured treatment interruptions to control HIV-1 and limit drug exposure

      TRENDS IN IMMUNOLOGY
    26. Imami, N; Hardy, G; Gotch, F
      Development of immunotherapeutic strategies for HIV-1

      EXPERT OPINION ON BIOLOGICAL THERAPY
    27. Soni, N; Pozniak, A
      Continuing HIV therapy in the ICU

      CRITICAL CARE
    28. Gajdatsy, AD; Tay-Kearney, ML
      Microsporidial keratoconjunctivitis after HAART

      CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    29. Rossi, M; Flepp, M; Telenti, A; Schiffer, V; Egloff, N; Bucher, H; Vernazza, P; Bernasconi, E; Weber, R; Rickenbach, M; Furrer, H
      Disseminated M-avium complex infection in the Swiss HIV cohort study: Declining incidence, improved prognosis and discontinuation of maintenance therapy

      SWISS MEDICAL WEEKLY
    30. Flepp, M; Schiffer, V; Weber, R; Hirschel, B
      Modern anti-HIV therapy

      SWISS MEDICAL WEEKLY
    31. Mijch, AM; Hoy, J; Watson, K; Dunne, A; Crowe, S; Wesselingh, SL
      Does plasma HIV RNA predict outcome in a cohort of treated HIV-infected individuals followed over 3 years?

      JOURNAL OF CLINICAL VIROLOGY
    32. Pett, SL; Emery, S
      Immunomodulators as adjunctive therapy for HIV-1 infection

      JOURNAL OF CLINICAL VIROLOGY
    33. Zollner, B; Feucht, HH; Weitner, L; Adam, A; Schroter, M; Schafer, P; Laufs, R
      Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients

      JOURNAL OF CLINICAL VIROLOGY
    34. Alfano, M; Poli, G
      Cytokine and chemokine based control of HIV infection and replication

      CURRENT PHARMACEUTICAL DESIGN
    35. Brook, MG; Miller, RF
      HIV associated nephropathy: a treatable condition

      SEXUALLY TRANSMITTED INFECTIONS
    36. Lange, J
      A rational approach to the selection and sequencing of nucleoside/nucleotide analogues: a new paradigm

      ANTIVIRAL THERAPY
    37. Hoetelmans, R
      Pharmacological exposure and the development of drug resistance in HIV

      ANTIVIRAL THERAPY
    38. Weber, T; Weber, F; Petry, H; Luke, W
      Immune response in progressive multifocal leukoencephalopathy: An overview

      JOURNAL OF NEUROVIROLOGY
    39. Antinori, A; Ammassari, A; Giancola, ML; Cingolani, A; Grisetti, S; Murri, R; Alba, L; Ciancio, B; Soldani, F; Larussa, D; Ippolito, G; De Luca, A
      Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era

      JOURNAL OF NEUROVIROLOGY
    40. Berger, JR; Chauhan, A; Galey, D; Nath, A
      Epidemiological evidence and molecular basis of interactions between HIV and JC virus

      JOURNAL OF NEUROVIROLOGY
    41. Geschwind, MD; Skolasky, RI; Royal, WS; McArthur, JC
      The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS

      JOURNAL OF NEUROVIROLOGY
    42. Cinque, P; Pierotti, C; Vigano, MG; Bestetti, A; Fausti, C; Bertelli, D; Lazzarin, A
      The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy

      JOURNAL OF NEUROVIROLOGY
    43. De Luca, A; Giancola, ML; Ammassari, A; Grisetti, S; Cingolani, A; Larussa, D; Alba, L; Murri, R; Ippolito, G; Cauda, R; Monforte, AD; Antinori, A
      Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study

      JOURNAL OF NEUROVIROLOGY
    44. Yiannoutsos, CT; De Luca, A
      Designs for clinical trials to test the efficacy of therapeutics in progressive multifocal leukoencephalopathy

      JOURNAL OF NEUROVIROLOGY
    45. Gasnault, J; Kousignian, P; Kahraman, M; Rahoiljaon, J; Matheron, S; Delfraissy, JF; Taoufik, Y
      Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: Amonocenter observational study with clinical and JC virus load monitoring

      JOURNAL OF NEUROVIROLOGY
    46. Rausch, DM; Davis, MR
      HIV in the CNS: Pathogenic relationships to systemic HIV disease and otherCNS diseases

      JOURNAL OF NEUROVIROLOGY
    47. Garcia-Viejo, MA; Ruiz, M; Martinez, E
      Strategies for treating HIV-related lipodystrophy

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    48. Selliah, N; Finkel, TH
      Biochemical mechanisms of HIV induced T cell apoptosis

      CELL DEATH AND DIFFERENTIATION
    49. Plosker, GL; Perry, CM; Goa, KL
      Efavirenz - A pharmacoeconomic review of its use in HIV infection

      PHARMACOECONOMICS
    50. Caro, JJ; O'Brien, JA; Migliaccio-Walle, K; Raggio, G
      Economic analysis of initial HIV treatment - Efavirenz- versus indinavir-containing triple therapy

      PHARMACOECONOMICS
    51. Regazzi, MB; Seminari, E; Villani, P; Carriero, PL; Montagna, M; Marubbi, F; Maserati, R
      Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profile

      JOURNAL OF CHEMOTHERAPY
    52. Sothinathan, R; Briggs, WA; Eustace, JA
      Treatment of HIV-associated nephropathy

      AIDS PATIENT CARE AND STDS
    53. Maisels, L; Steinberg, J; Tobias, C
      An investigation of why eligible patients do not receive HAART

      AIDS PATIENT CARE AND STDS
    54. Sonza, S; Crowe, SM
      Reservoirs for HIV infection and their persistence in the face of undetectable viral load

      AIDS PATIENT CARE AND STDS
    55. Altfeld, M; Walker, BD
      Less is more? STI in acute and chronic HIV-1 infection

      NATURE MEDICINE
    56. Stoddart, CA; Liegler, TJ; Mammano, F; Linquist-Stepps, VD; Hayden, MS; Deeks, SG; Grant, RM; Clavel, F; McCune, JM
      Impaired replication of protease inhibitor-resistant HIV-1 in human thymus

      NATURE MEDICINE
    57. Butler, SL; Hansen, MST; Bushman, FD
      A quantitative assay for HIV DNA integration in vivo

      NATURE MEDICINE
    58. Brooks, DG; Kitchen, SG; Kitchen, CMR; Scripture-Adams, DD; Zack, JA
      Generation of HIV latency during thymopoiesis

      NATURE MEDICINE
    59. Goldman, DP; Leibowitz, AA; Joyce, GF; Shapiro, MF; Bozzette, SA
      The impact of state policy on the costs of HIV infection

      MEDICAL CARE RESEARCH AND REVIEW
    60. Piccinini, G; Comolli, G; Genini, E; Lilleri, D; Gulminetti, R; Maccario, R; Revello, MG; Gerna, G
      Comparative analysis of human cytomegalovirus-specific CD4(+) T-cell frequency and lymphoproliferative response in human immunodeficiency virus-positive patients

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    61. De Paoli, P
      Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    62. Segarra-Newnham, M; Vodolo, KM
      Use of cidofovir in progressive multifocal leukoencephalopathy

      ANNALS OF PHARMACOTHERAPY
    63. John, L; Marra, F; Ensom, MHH
      Role of therapeutic drug monitoring for protease inhibitors

      ANNALS OF PHARMACOTHERAPY
    64. Smith, SR; Buchanan, RJ
      The AIDS drug assistance programs and coverage of HIV-related medications

      ANNALS OF PHARMACOTHERAPY
    65. Kilby, JM
      Human immunodeficiency virus pathogenesis: Insights from studies of lymphoid cells and tissues

      CLINICAL INFECTIOUS DISEASES
    66. McNeil, MM; Nash, SL; Hajjeh, RA; Phelan, MA; Conn, LA; Plikaytis, BD; Warnock, DW
      Trends in mortality due to invasive mycotic diseases in the United States,1980-1997

      CLINICAL INFECTIOUS DISEASES
    67. Trikalinos, TA; Ioannidis, JPA
      Discontinuation of Pneumocystis carinii prophylaxis in patients infected with human immunodeficiency virus: A meta-analysis and decision analysis

      CLINICAL INFECTIOUS DISEASES
    68. Horsburgh, CR; Gettings, J; Alexander, LN; Lennox, JL
      Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000

      CLINICAL INFECTIOUS DISEASES
    69. Bahrani, A; Ramaswamy, R; Oldfield, EC
      Effects of virologic rebound on CD4 cell counts

      CLINICAL INFECTIOUS DISEASES
    70. Armstrong, WS; Kazanjian, P
      Use of cytokines in human immunodeficiency virus-infected patients: Colony-stimulating factors, erythropoietin, and interleukin-2

      CLINICAL INFECTIOUS DISEASES
    71. Phillips, P
      Immunoresititution disease in relation to infection with Mycobacterium avium complex and to leprosy

      CLINICAL INFECTIOUS DISEASES
    72. Collis, TK; Celum, CL
      The clinical manifestations and treatment of sexually transmitted diseasesin human immunodeficiency virus-positive men

      CLINICAL INFECTIOUS DISEASES
    73. Sereti, I; Lane, HC
      Immunopathogenesis of human immunodeficiency virus: Implications for immune-based therapies

      CLINICAL INFECTIOUS DISEASES
    74. Cohen, DE; Walker, BD
      Human immunodeficieny virus pathogenesis and prospects for immune control in patients with established infection

      CLINICAL INFECTIOUS DISEASES
    75. Currier, JS; Williams, P; Feinberg, J; Becker, S; Owens, S; Fichtenbaum, C; Benson, C
      Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease

      CLINICAL INFECTIOUS DISEASES
    76. Murphy, EL; Assmann, SF; Collier, AC; Flanigan, TP; Kumar, PN; Wallach, FR; Krubel, S
      Determinants of antimicrobial prophylaxis use and treatment for wasting among patients with advanced human immunodeficiency virus disease in the United States, 1995-1998

      CLINICAL INFECTIOUS DISEASES
    77. Martinez, EH
      Hepatitis B and hepatitis C co-infection in patients with HIV

      REVIEWS IN MEDICAL VIROLOGY
    78. Huang, JS; Grinspoon, S
      HIV and bone metabolism

      ENDOCRINOLOGIST
    79. Witzke, O; Winterhagen, T; Saller, B; Roggenbuck, U; Lehr, I; Philipp, T; Mann, K; Reinhardt, W
      Transient stimulatory effects on pituitary-thyroid axis in patients treated with interleukin-2

      THYROID
    80. Kulmatycki, KM; Jamali, F
      Therapeutic relevance of altered cytokine expression

      CYTOKINE
    81. Stylianou, E; Aukrust, P; Muller, F; Nordoy, I; Froland, SS
      Complex effects of interferon-alpha on the cytokine network in HIV infection - Possible contribution to immunosuppression

      CYTOKINE
    82. Clarke, CA; Glaser, SL
      Epidemiologic trends in HIV-associated lymphomas

      CURRENT OPINION IN ONCOLOGY
    83. Orlovic, D; Smego, RA
      Paradoxical tuberculous reactions in HIV-infected patients

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    84. Sackoff, JE; Torian, LV; Frieden, TR
      TB prevention in HIV clinics in New York City

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    85. Palu, G; Pira, GL; Gennari, F; Fenoglio, D; Parolin, C; Manca, F
      Genetically modified immunocompetent cells in HIV infection

      GENE THERAPY
    86. Donnelly, CA; Cox, DR
      Mathematical biology and medical statistics: contributions to the understanding of AIDS epidemiology

      STATISTICAL METHODS IN MEDICAL RESEARCH
    87. Levine, AM; Tulpule, A
      Clinical aspects and management of AIDS-related Kaposi's sarcoma

      EUROPEAN JOURNAL OF CANCER
    88. Tirelli, U; Bernardi, D
      Impact of HAART on the clinical management of AIDS-related cancers

      EUROPEAN JOURNAL OF CANCER
    89. Muise, A; Arbess, G
      The risk of myocardial infarction in HIV-infected patients receiving HAART: a case report

      INTERNATIONAL JOURNAL OF STD & AIDS
    90. Segal, R; Poznansky, MC; Connors, L; Sands, K; Barlam, T
      Changing patterns of presentations of patients with HIV-related disease ata tertiary referral centre and its implications for physician training

      INTERNATIONAL JOURNAL OF STD & AIDS
    91. Pradier, C; Carrieri, P; Bentz, L; Spire, B; Dellamonica, P; Moreau, J; Moatti, JP
      Impact of short-term adherence on virological and immunological success ofHAART: a case study among French HIV-infected IDUs

      INTERNATIONAL JOURNAL OF STD & AIDS
    92. Manfredi, R; Chiodo, F
      Switch of protease inhibitor-containing HAART in routine clinical practice: a four-year prospective observational study

      INTERNATIONAL JOURNAL OF STD & AIDS
    93. Quah, SP; McBride, M
      A case of pneumocystis pneumonia after cessation of secondary prophylaxis

      INTERNATIONAL JOURNAL OF STD & AIDS
    94. Skiest, DJ; Chiller, T; Chiller, K; Park, A; Keiser, P
      Protease inhibitor therapy is associated with markedly prolonged time to relapse and improved survival in AIDS patients with cytomegalovirus retinitis

      INTERNATIONAL JOURNAL OF STD & AIDS
    95. Kingston, MA; Bowman, CA
      The investigation of patients with HIV infection: 10 years of progress

      INTERNATIONAL JOURNAL OF STD & AIDS
    96. Nouts, C; Bonarek, M; Morlat, P; Delevaux, I; Bonnet, F; Lacoste, D; Bernard, N; Beylot, J
      The absence of hyperbilirubinaemia is highly predictive of treatment failure in advanced HIV-infected patients treated with indinavir

      INTERNATIONAL JOURNAL OF STD & AIDS
    97. Vernazza, PL; Kashuba, ADM; Cohen, MS
      Biological correlates of sexual transmission of HIV: practical consequences and potential targets for public health

      REVIEWS IN MEDICAL MICROBIOLOGY
    98. Sharkey, ME; Stevenson, M
      Two long terminal repeat circles and persistent HIV-1 replication

      CURRENT OPINION IN INFECTIOUS DISEASES
    99. Hazenberg, MD; Verschuren, MCM; Hamann, D; Miedema, F; van Dongen, JJM
      T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation

      JOURNAL OF MOLECULAR MEDICINE-JMM
    100. Murray, R; Mallal, S; Heath, C; French, M
      Cerebral Mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated Mycobacterium avium complex infection

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 07:59:35